Home / Gabapentin / Italy
IT ATC N02BF01 · updated 2 Nov 2026
Gabapentin shortage in Italy
Is there a Gabapentin shortage in Italy?
Yes. As of 2 Nov 2026, 8 Gabapentin products are reported short in Italy, the first since 22 Aug 2022. The company estimate for the return is 31 Dec 2026 (latest 30 Jun 2027). Main reason: manufacturing problem.
Also short in Canada, Spain, Ireland, Austria, Belgium, Czechia, Norway, Sweden. All countries.
Affected products in Italy
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| IT | GABAPENTIN ZENTIVA | ZENTIVA ITALIA S.R.L. | 22 Aug 2022 | not given | Manufacturing problem Problemi produttivi |
| IT | GABAPENTIN ZENTIVA | ZENTIVA ITALIA S.R.L. | 6 Feb 2023 | not given | Manufacturing problem Problemi produttivi |
| IT | GABAPENTIN ZENTIVA | ZENTIVA ITALIA S.R.L. | 20 Mar 2023 | not given | Manufacturing problem Problemi produttivi |
| IT | GABAPENTIN MYLAN GENERICS | MYLAN S.P.A. | 1 Apr 2024 | not given | Manufacturing problem Problemi produttivi |
| IT | GABAPENTIN MYLAN GENERICS | MYLAN S.P.A. | 19 Feb 2026 | not given | Manufacturing problem Problemi produttivi |
| IT | GABAPENTIN MYLAN GENERICS | MYLAN S.P.A. | 15 Apr 2026 | not given | Increased demand Elevata richiesta/problemi produttivi |
| IT | GABAPENTIN PENSA | TOWA PHARMACEUTICAL S.P.A. | 1 Jul 2026 | 31 Dec 2026 | Manufacturing problem Problemi produttivi |
| IT | GABAPENTIN PENSA anticipated | TOWA PHARMACEUTICAL S.P.A. | 16 Nov 2026 | 30 Jun 2027 | Increased demand Elevata richiesta/problemi produttivi |
Source
AIFA (Italian Medicines Agency), licensed CC-BY 4.0. Official list. All shortages reported by marketing-authorisation holders, including medicines being withdrawn.